Analyst Ratings For Menlo Therapeutics (NASDAQ:MNLO)
Today, JMP Securities initiated coverage on Menlo Therapeutics (NASDAQ:MNLO) with a Outperform with a price target of $44.00.
Some recent analyst ratings include
- 2/20/2018-JMP Securities initiated coverage with a Outperform rating.
- 2/20/2018-Piper Jaffray Companies initiated coverage with a Overweight rating.
- 2/20/2018-Jefferies Group initiated coverage with a Buy rating.
- 2/19/2018-Guggenheim initiated coverage with a Buy rating.
Recent Trading Activity for Menlo Therapeutics (NASDAQ:MNLO)
Shares of Menlo Therapeutics closed the previous trading session at 33.93 down -0.95 2.74% with 33.46780014038086 shares trading hands.